NIH-funded research NIH-funded research

Understanding how persistent DNA damage affects the immune response in aging

Official title: A beneficial persistent DNA damage-induced immune response in aging

Funded at University of Pittsburgh at Pittsburgh · NIH-11175787 · Data updated 2026-11-12

This study is looking at how our immune system reacts to ongoing DNA damage, especially as we age or if we have certain blood disorders, and it focuses on a protein called NLRP12 that might help improve blood stem cells; the goal is to find ways to boost health in older adults and those with these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 17, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$709,654
NIH project number1R56HL169348-01A1
Project IDNIH-11175787 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults and individuals with conditions related to DNA repair deficiencies or blood disorders.

Less likely to help

Patients who are younger and do not have any issues related to DNA repair or blood disorders may not benefit from this research.

What this research studies

This research investigates the immune responses triggered by persistent DNA damage, particularly in the context of aging and diseases related to DNA repair deficiencies. The study focuses on a specific protein, NLRP12, which is believed to enhance the function of blood-forming stem cells when activated by persistent DNA damage. By exploring the mechanisms behind this immune response, the research aims to uncover how these processes can be harnessed to improve health outcomes in older adults and those with certain blood disorders. The approach includes both animal models and human samples to validate findings and understand their implications.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance immune function and improve health in aging populations.

How similar studies have gone: Other research has shown promising results in understanding immune responses related to DNA damage, but this specific approach focusing on persistent damage and NLRP12 is relatively novel.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Du, Wei — University of Pittsburgh at Pittsburgh
  • Study coordinator: Du, Wei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.